Experimental feature

Listen to this article

Experimental feature

September 15: Kate Burgess clearly hit a rich seam this morning with her overnight scoop that BP investors are demanding meetings with the company to discuss its recent problems. She’s been taking calls from others this morning wanting to vent on the same topic and we have more detail about what investors have been telling us this week which didn’t make it into this morning’s edition. For an alternative view on BP and why Lord Browne should not get so distracted with all this Beyond Petroleum stuff, go to antigreen.blogspot.com where John Ray says: “Earth to Lord Browne: Gasoline is a miracle product upon which our civilisation depends.”

AstraZeneca and Bayer’s Schering unit are to co-operate on the development of a new breast cancer drug. It’s an interesting example of how the industry is sharing what is in effect venture capital risk, and also an example of David Brennan’s desperate search to fill that rather too hollow pipeline.

Arsenal denies this morning’s story in The Sun that a group including a Russian billionaire is interested in bidding for the club. The Gunners put out a statement saying they had not received a takeover approach yet, which of course does not mean one is not in the offing.

We’ll also do more later on Ed Balls’s proposed legislation to protect the London Stock Exchange from US regulation. And we have some fascinating stuff on the impact of the wars in Iraq and Afghanistan on business.

To make or read a comment click here

For previous blogs, click here

Get alerts on Columnists when a new story is published

Copyright The Financial Times Limited 2019. All rights reserved.

Comments have not been enabled for this article.

Follow the topics in this article